Showing results (71-80 of 94) with videos related to

Sort By:
Pageof 10
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 31, 1998
Phase I chemoprevention study of piroxicam and alpha-difluoromethylornithineP P Carbone, J A Douglas, P O Larson, et al.
Journal of the National Cancer Institute|May 5, 1993
Randomized phase I chemoprevention dose-seeking study of alpha-difluoromethylornithineR R Love, P P Carbone, A K Verma, et al.
Cancer Treatment Reports|September 1, 1978
Phase II study of adriamycin and bleomycin in patients with multiple myelomaJ M Bennett, R Silber, E Ezdinli, et al.
Journal of the National Cancer Institute|August 15, 1990
Effects of tamoxifen therapy on lipid and lipoprotein levels in postmenopausal patients with node-negative breast cancerR R Love, P A Newcomb, D A Wiebe, et al.
Cancer Treatment Reports|July 1, 1978
Phase II study of vinblastine, methyl-CCNU, and medroxyprogesterone in advanced renal cell cancerR G Hahn, N R Temkin, E D Savlov, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1984
Aggressive combined modality therapy for advanced local-regional breast carcinomaC L Loprinzi, P P Carbone, D C Tormey, et al.
Cancer|February 1, 1979
Eastern Cooperative Oncology Group experience with the rappaport classification of non-Hodgkin's lymphomasE Z Ezdinli, W Costello, L P Wasser, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1985
Adjuvant CMFP versus CMFP plus tamoxifen versus observation alone in postmenopausal, node-positive breast cancer patients: three-year results of an Eastern Cooperative Oncology Group studyS G Taylor, L A Kalish, J E Olson, et al.
Cancer|November 1, 1983
Cooperative groups and community hospitals. Measurement of impact in the community hospitalsC B Begg, M Zelen, P P Carbone, et al.
Cancer|January 15, 1980
Cyclophosphamide, cytosine arabinoside and methotrexate versus cytosine arabinoside and thioguanine for acute non-lymphocytic leukemia in adultsR T Skeel, W Costello, J M Bennett, et al.
Pageof 10